Feisal Othman

Structured Benefit-risk Assessment Lead at Bristol-Myers Squibb

Feisal Othman has extensive experience in risk management and pharmacovigilance, currently serving as Associate Director of Global Risk Management Strategy at Bristol Myers Squibb since August 2020. Prior to this role, Feisal Othman worked at Lundbeck from June 2014 to August 2020, holding positions including Associate Director of Risk Management Global Pharmacovigilance US and Sr. Manager of Risk Management GPV U.S. Earlier in the career, Feisal Othman spent over a decade at Walgreens in various roles, such as Product Manager for Digital Consumer Health and Chief Pharmacist. Feisal Othman earned a Pharm.D. degree in Pharmacy from Midwestern University (1998-2003) and a Bachelor of Science in Biology from the University of Illinois Chicago (1993-1996).

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices